Skip to main content

Published locations for Donafenib shows potential as first-line treatment of advanced hepatocellular carcinoma

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Donafenib shows potential as first-line treatment of advanced hepatocellular carcinoma

User login

  • Reset your password
  • /content/donafenib-shows-potential-first-line-treatment-advanced-hepatocellular-carcinoma
  • /fedprac/article/247588/gastroenterology/donafenib-shows-potential-first-line-treatment-advanced
  • /gihepnews/article/247588/gastroenterology/donafenib-shows-potential-first-line-treatment-advanced
  • /internalmedicinenews/article/247588/gastroenterology/donafenib-shows-potential-first-line-treatment
  • /oncologypractice/article/247588/gastroenterology/donafenib-shows-potential-first-line-treatment
  • /fedprac/avaho/article/247588/gastroenterology/donafenib-shows-potential-first-line-treatment
  • /hematology-oncology/article/247588/gastroenterology/donafenib-shows-potential-first-line-treatment
  • /internalmedicine/article/247588/gastroenterology/donafenib-shows-potential-first-line-treatment